Daniel Paul Regan - Net Worth and Insider Trading

Daniel Paul Regan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Daniel Paul Regan owns 2 companies in total, including Keryx Biopharmaceuticals Inc (KERX) , and Intercept Pharmaceuticals Inc (ICPT) .

Click here to see the complete history of Daniel Paul Regan’s form 4 insider trades.

Insider Ownership Summary of Daniel Paul Regan

Ticker Comapny Transaction Date Type of Owner
KERX Keryx Biopharmaceuticals Inc 2018-12-12 director
ICPT Intercept Pharmaceuticals Inc 2013-03-04 Chief Commerical Officer

Daniel Paul Regan Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Daniel Paul Regan Ownership Network

Ownership Network List of Daniel Paul Regan

No Data

Ownership Network Relation of Daniel Paul Regan


Daniel Paul Regan Owned Company Details

What does Keryx Biopharmaceuticals Inc do?

Who are the key executives at Keryx Biopharmaceuticals Inc?

Daniel Paul Regan is the director of Keryx Biopharmaceuticals Inc. Other key executives at Keryx Biopharmaceuticals Inc include director & Interim CEO Jodie Pope Morrison , Chief Financial Officer Scott A Holmes , and 10 percent owner Baupost Group Gp, L.l.c. .

Keryx Biopharmaceuticals Inc (KERX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Keryx Biopharmaceuticals Inc (KERX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Keryx Biopharmaceuticals Inc (KERX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Keryx Biopharmaceuticals Inc (KERX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Keryx Biopharmaceuticals Inc Insider Transactions

No Available Data

Daniel Paul Regan Mailing Address

Above is the net worth, insider trading, and ownership report for Daniel Paul Regan. You might contact Daniel Paul Regan via mailing address: C/o Intercept Pharmaceuticals, Inc., 18 Desbrosses St., New York Ny 10013.

Discussions on Daniel Paul Regan

No discussions yet.